Retrospective Cohort Study: Nomogram for 1-Year in-Stent Restenosis After PCI in Coronary Heart Disease

Xin-Fu Cao1, Dao-Hai Chen1, Ya-Li Qiu2

  • 1Department of Cardiology, Changzhou Affiliated Hospital of Nanjing University of Chinese Medicine, Changzhou, Jiangsu, People's Republic of China.

Insights

This study developed a nomogram to predict in-stent restenosis (ISR) after coronary artery stenting. Key risk factors include diabetes, high neutrophil/lymphocyte ratio, elevated LDL, calcified lesions, small stent diameter, smoking, and lack of intravascular ultrasound assistance.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Informatics

Background:

  • In-stent restenosis (ISR) is a significant complication following percutaneous coronary intervention (PCI) for coronary heart disease (CHD).
  • Accurate risk prediction is crucial for optimizing patient management and preventing ISR.

Purpose of the Study:

  • To develop and validate a nomogram for predicting the risk of ISR within one year after PCI in CHD patients.
  • To identify independent predictors of ISR to aid in clinical decision-making.

Main Methods:

  • A cohort of 842 severe CHD patients undergoing PCI was analyzed.
  • Risk factors were identified using LASSO and multivariate logistic regression.
  • A nomogram was constructed and validated using bootstrap resampling, ROC analysis, calibration curves, and decision curve analysis (DCA).

Main Results:

  • Seven independent risk factors for ISR were identified: diabetes, neutrophil/lymphocyte ratio (NLR), low-density lipoprotein (LDL) > 1.8 mmol/L, calcified lesions, stent diameter < 3 mm, smoking, and absence of intravascular ultrasound (IVUS) assistance.
  • The nomogram demonstrated excellent discriminative ability (AUC = 0.892) and predictive accuracy (C-index = 0.923).
  • The model showed strong clinical utility, with calcified lesions, stent diameter < 3 mm, and no IVUS assistance being the most influential factors.

Conclusions:

  • The developed nomogram effectively predicts the risk of ISR in CHD patients post-PCI.
  • The model possesses good predictive efficiency and clinical applicability, aiding in risk stratification and personalized treatment strategies.
Abstract